Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report.
Mashitani T, Yoshiji H, Yamazaki M, Ikenaka Y, Noguchi R, Ishikawa M, Kawaratani H, Matsuo N, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Yoshida M, Sawai M, Morioka C, Tsujimoto T, Kitade M, Kaji K, Aihara Y, Fukui H. Mashitani T, et al. Among authors: aihara y. Cases J. 2009 Jan 7;2(1):18. doi: 10.1186/1757-1626-2-18. Cases J. 2009. PMID: 19128460 Free PMC article.
Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat.
Yoshiji H, Noguchi R, Ikenaka Y, Namisaki T, Kitade M, Kaji K, Shirai Y, Yoshii J, Yanase K, Yamazaki M, Tsujimoto T, Kawaratani H, Akahane T, Aihara Y, Fukui H. Yoshiji H, et al. Among authors: aihara y. BMC Res Notes. 2009 May 5;2:70. doi: 10.1186/1756-0500-2-70. BMC Res Notes. 2009. PMID: 19416517 Free PMC article.
Impact of renin-angiotensin system in hepatocellular carcinoma.
Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Fukui H. Yoshiji H, et al. Among authors: aihara y. Curr Cancer Drug Targets. 2011 May;11(4):431-41. doi: 10.2174/156800911795538084. Curr Cancer Drug Targets. 2011. PMID: 21395547 Review.
Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report.
Shirai Y, Yoshiji H, Ko S, Yamazaki M, Ikenaka Y, Noguchi R, Morioka C, Kaji K, Aihara Y, Nakanishi K, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Fujimoto M, Uemura M, Nakajima Y, Fukui H. Shirai Y, et al. Among authors: aihara y. J Med Case Rep. 2011 Mar 29;5:124. doi: 10.1186/1752-1947-5-124. J Med Case Rep. 2011. PMID: 21447168 Free PMC article.
Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial.
Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Yamazaki M, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Morioka C, Fujimoto M, Uemura M, Fukui H. Yoshiji H, et al. Among authors: aihara y. Oncol Rep. 2011 Dec;26(6):1547-53. doi: 10.3892/or.2011.1433. Epub 2011 Aug 24. Oncol Rep. 2011. PMID: 21874260 Clinical Trial.
Combination of branched-chain amino acid and angiotensin-converting enzyme inhibitor improves liver fibrosis progression in patients with cirrhosis.
Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Douhara A, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Morioka C, Fujimoto M, Uemura M, Fukui H. Yoshiji H, et al. Among authors: aihara y. Mol Med Rep. 2012 Feb;5(2):539-44. doi: 10.3892/mmr.2011.676. Epub 2011 Nov 15. Mol Med Rep. 2012. PMID: 22089860 Clinical Trial.
A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma.
Aihara Y, Yoshiji H, Yamazaki M, Ikenaka Y, Noguchi R, Morioka C, Kaji K, Tastumi H, Nakanishi K, Nakamura M, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Fujimoto M, Uemura M, Fukui H. Aihara Y, et al. World J Gastrointest Oncol. 2012 May 15;4(5):115-8. doi: 10.4251/wjgo.v4.i5.115. World J Gastrointest Oncol. 2012. PMID: 22645635 Free PMC article.
Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents.
Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Aihara Y, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Morioka C, Fujimoto M, Uemura M, Kawaratani H, Tsujimoto T, Fukui H. Yoshiji H, et al. Among authors: aihara y. Oncol Lett. 2011 Jan;2(1):69-73. doi: 10.3892/ol.2010.196. Epub 2010 Oct 5. Oncol Lett. 2011. PMID: 22870131 Free PMC article.
446 results